论文部分内容阅读
目的:评价阿奇霉素与孟鲁司特钠联用对小儿肺炎支原体肺炎患者的临床疗效。方法:选取2014年2月—2015年2月间收治的小儿肺炎支原体肺炎患者80例,采用随机数字表法将其分为观察组(n=40)和对照组(n=40);对照组患者均给予阿奇霉素治疗,观察组患者在对照组基础上加用孟鲁司特钠治疗,评价两组患儿治疗后的总有效率和临床各指标的变化情况。结果:观察组患者临床治疗后的总有效率为92.50%高于对照组为77.50%(P<0.05),症状消失时间和住院时间短于对照组(P<0.05)。结论:针对小儿肺炎支原体肺炎病例,采用阿奇霉素与孟鲁司特钠联用治疗可缓解其临床症状,缩短住院时间。
Objective: To evaluate the clinical effect of azithromycin combined with montelukast on children with Mycoplasma pneumoniae pneumonia. Methods: Eighty children with mycoplasma pneumoniae pneumonia admitted from February 2014 to February 2015 were selected and divided into observation group (n = 40) and control group (n = 40) by random number table. The control group Patients were treated with azithromycin. Patients in the observation group were treated with montelukast sodium on the basis of the control group, and the total effective rate and changes of clinical indexes in both groups were evaluated. Results: The total effective rate of the observation group after treatment was 92.50% higher than that of the control group (77.50%) (P <0.05). The disappearance time and hospitalization time of the observation group were shorter than those of the control group (P <0.05). Conclusion: In the case of children with Mycoplasma pneumoniae pneumonia, azithromycin combined with montelukast can relieve the clinical symptoms and shorten the hospital stay.